(Q52225534)

English

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group. (English)

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

5

object named as

T K Kvien

1 reference

Europe PubMed Central

27 April 2018

author name string

J S Smolen

1

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

J R Kalden

2

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

D L Scott

3

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

B Rozman

4

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

A Larsen

6

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

I Loew-Friedrich

7

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

C Oed

8

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

R Rosenburg

9

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

353

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

259-266

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

9149

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Early rheumatoid arthritis--onset, course, and outcome over 2 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of T-lymphocytes and cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of C-reactive protein measurement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909403-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(98)09403-3

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/9929017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52225534&oldid=1400030963"